Summary.-Repeated injections of NAD led to a dose-dependent inhibition of cell proliferation in tumour-bearing mice (Ehrlich ascites carcinoma and a murine mastocytoma). NAD proved clearly superior to other adenine nucleotides, including 3',5'-cyclic AMP. Experiments with differently labelled NAD and studies on HeLa cultures showed that NAD is relatively slowly degraded by extracellular enzymes to AMP and adenosine, which probably represents the true cytostatic agent.
IT has been shown by several groups that 3',5'-cyclic AMP (cAMP) and other cyclic nucleotides are inhibitors of cell proliferation in various malignant cell lines in vitro and in vivo (Ryan and Heidrick, 1968; Gericke and Chandra, 1969; Heidrick and Ryan, 1970; Chandra, Gericke and Wacker, 1971) . The physiological significance of these results is not clear, especially since we could demonstrate in HeLa cultures that exogenous NAD and other adenine derivatives were also potent inhibitors of cell proliferation (Nolde and Hilz, 1972) . Even at 3 X 10-5 mol/l concentrations NAD acted as a cytostatic, being somewhat superior to cAMP and other adenine nucleotides. NAD did not permeate the HeLa cells but was degraded extracellularly to AMP, adenosine and other derivatives. The pyridine-containing split products were not inhibitorv. All the evidence pointed to adenosine as the true cytostatic agent. In cell culture experiments, adenosine was indeed the most potent cytostatic compound, followed by NAD and the other adenine derivatives. When we tried NAD as an inhibitor of tumour cell proliferation in mice, NAD proved to be clearly superior to adenosine and to adenine nucleotides. A cytostatic action of NAD has also been shown by Matsuyama, Maekawa and Nagayo (1961) . The results presented here indicate a new kind of " poisoning " of a compound brought about by the action of extracellular enzymes.
MATERIALS AND METHODS
The animals used were adult (25-30 g) female mice (Balb c). They were maintained in plastic cages on conventional laboratory feeds. The experimental tumours used were Ehrlich ascites carcinoma and a murine mastocytoma kindly supplied by Dr Karzel (Pharmakologisches Institut, Universitat Bonn). Male mice bearing 6-7 day-old tumours served as donors. For the experiments, the original ascites fluid was diluted 1: 10 with isotonic saline and groups of 10 mice were injected intraperitoneally with 01 ml of the dilution (8-5 x 105 ± 0-14 X 105 cells). Treatment was started the day after inoculation, with 10 animals in each group. Each animal received 200 ,ul of 6'0, containing the freshly neutralized compound; the controls received buffered saline alone. Injections were repeated every second day; in some cases, injections were given daily. On termination of the experiment, the ascites of the whole group was pooled and analysed for cell number (Coulter counter), cell volume (haematocrit) and other parameters (see Fig. 1 and Tables).
Nucleotides were purchased from E. Merck, Darmstadt, and from Boehringer, Mannheim. 3H-adenine-labelled and 3H-nicotinamide-labelled NAD were synthesized as described previously (Nolde and Hilz, 1972) . Intraperitoneal injections were given on the first, third and fifth day after transplantation (9 4 x 105 cells). Cells were harvested at the seventh day, and counted as described in the text. superior to AMP and to adenosine in EAC cells (Table II) . Nicotinamide (NAm), which is active as a cytostatic at very high concentrations (Matsuyama et al., 1961) , showed insignificant effects at these concentrations (Table II) . In mastocytoma cells, NAD was somewhat less effective but always surpassed the action of adenosine or AMP. A representative experiment is presented in Table III . With the concentrations used, cell proliferation cannot be suppressed completely. Prolonged treatment kept values well below the controls, but the increase in weight due to an increase in ascites continued though at a reduced rate. NAD per se did not significantly alter the weight of normal animals (not shown).
The mechanism of inhibition must be different from the action of alkylating agents. While these lead to the formation of giant cells at concentrations producing partial inhibition of cell proliferation (Cohen and Studzinski, 1967; Schlager, Oldekop and Hilz, 1970) , NAD (and other adenine derivatives) caused only slight increases in cell volume (Table IV) . The treated cells also showed an elevated rate of 3H-thymidine incorporation into DNA (Table IV) in spite of the retarded cell multiplication, as has also been observed in HeLa cultures (Table VI) .
The damage to EAC cells exposed to repeated NAD injections is indicated by an increased level of lactate dehydrogenase (LDH) in the ascitic serum as well as in the cells (Table IV) .
NAD does not permeate the cells as an intact compound. When differently labelled NAD samples of the same specific radioactivity were exposed to EAC cells, the uptake of label was strikingly different (Fig. 1) NAD, when applied in a DMSO solution to Harding-Passey melanoma in mice, again led to a significant retardation of tumour growth (Sloty et al., 1971) . At mmolar concentrations, adenosine was the most effective compound in HeLa cultures, while 3 x 10-4 mol/l concentrations were considerably less effective (Table VI) . In contrast, raising NAD levels above 3 x 10-4 mol/l increased only slightly the cytostatic effect (or moderately depending on the batch of serum used for the medium). This difference may be explained by differences in metabolism: adenosine is rapidly taken up by the cells and degraded or converted to purine nucleotides. To guarantee an effective level of the nucleoside during the 24-hour incubation period, a high concentration had to be applied. NAD on the other hand persisted much longer (Table V) . The rate-limiting step for the degradation of NAD is the hydrolytic cleavage to AMP by a phosphodiesterase present in Cell volume was calculated from " haematocrit " reading and cell number. DNA was determined according to Burton (1968) . 3H-thymidine labelling of DNA was carried out with 6 x 106 pooled cells resuspended in 2 50 ml of fresh ascites serum of the corresponding group supplemented with 1 ,uC of 3H-thymidine (specific radioactivity 25 mCi/mmol, The Radiochemical Centre, Amersham). After incubation for 10 min at 370 C, acid insoluble radioactivity was determined according to Bollum (1959) . LDH activity was determined according to Bergmeyer et al. (1962) . 172±3 (n=2) Adenine 3 x 10-4 mol/l . 92+14 (n=2) Adenosine 3 x10-4mo/l .
64+11 (n=8)
.
159+13 (n=5) 1 x 10-3 mol/l . 13 ± 9* (n = 7) * 119±8 (n = 3) * Negative values represent cytotoxic action with detachment of cells from the glass surface in addition to complete inhibition of proliferation.
Mean and SEM values from separate experiments (each in duplicate) with monolayer cultures (about 2-5 x 106cell/flask, 10 ml F-13 medium containing 5% calf serum). The neutralized compounds were added for 24 hours. Proliferation was determined as the increase in cells/flask in 24 hours. Control values were 2-3 + 0-I x 106 cells/flask. 3H-thymidine incorporation into DNA was measured by exposing cultures between hours 23 and 24 to 1 ,Ci of 3H-thymidine (specific radioactivity 15 -6 Ci/mmol, The Radiochemical Centre, Amersham, England). Incubation was stopped by pouring off the medium and washing the cells twice with 10 ml of ice-cold isotonic saline.
The cell pellet was homogenized in 0 50 ml of 0 5 N NaOH (00), 100 ul-aliquots were put on to filter papers and extracted according to Bollum (1959) . Control values were 7 50 ± 0 -66 x 103 cpm/106 cells.
